Methotrexate increases red blood cell concentrations of 6-methylmercaptopurine ribonucleotide in rats in vivo

被引:7
作者
Giverhaug, T
Fuskevaag, OM
Aarbakke, J
机构
[1] Department of Pharmacology, Institute of Medical Biology, University of Tromsø
关键词
methylmercaptopurine; 6-thioguanine nucleotide; interaction; metabolism;
D O I
10.1007/s002800050672
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To elucidate the effect of methotrexate (MTX) on 6-mercaptopurine (6-MP) metabolism in rats. Methods: Fourteen rats were given 6-MP 20 mg/kg daily for 7 days. Seven of the rats were also given MTX 20 mg/kg on days 5 and 7. Blood samples were obtained from all rats on days 0, 5 and 8, and red blood cell (RBC) lysates were analysed for thiopurine methyltransferase (TPMT) activity and the concentration of methylated 6-MP metabolites [methyl mercaptopurine ribonucleotides (MMPRP)] and 6-thioguanine nucleotides (6-TGN). Reslnlts: The concentration of MMPRP increased 2.4 times from day 5 to day 8 in RBCs from rats given MTX in addition to 6-MP, as against 1.2 times in rats given 6-MP alone (P = 0.003). 6-TGN levels increased and TPMT activity decreased from day 5 to day 8, with no difference between the 6-MP and the 6-MP plus MTX groups. Conclusions: Single bolus doses of MTX increase the concentration of MMPRP in rats given daily s.c. doses of 6-MP, with no effect on 6-TGN concentration or TPMT activity.
引用
收藏
页码:367 / 370
页数:4
相关论文
共 21 条
[1]   THE EFFECT OF METHOTREXATE ON THE BIOAVAILABILITY OF ORAL 6-MERCAPTOPURINE [J].
BALIS, FM ;
HOLCENBERG, JS ;
ZIMM, S ;
TUBERGEN, D ;
COLLINS, JM ;
MURPHY, RF ;
GILCHRIST, GS ;
HAMMOND, D ;
POPLACK, DG .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (04) :384-387
[2]  
BENNETT LL, 1971, CANCER RES, V31, P152
[3]  
Bokkerink J P, 1986, Adv Exp Med Biol, V195 Pt B, P135
[4]   SEQUENCE-DEPENDENT, TIME-DEPENDENT AND DOSE-DEPENDENT SYNERGISM OF METHOTREXATE AND 6-MERCAPTOPURINE IN MALIGNANT HUMAN T-LYMPHOBLASTS [J].
BOKKERINK, JPM ;
BAKKER, MAH ;
HULSCHER, TW ;
DEABREU, RRA ;
SCHRETLEN, EDAM ;
VANLAARHOVEN, JPRM ;
DEBRUYN, CHMM .
BIOCHEMICAL PHARMACOLOGY, 1986, 35 (20) :3549-3555
[5]   6-MERCAPTOPURINE - CYTOTOXICITY AND BIOCHEMICAL PHARMACOLOGY IN HUMAN-MALIGNANT T-LYMPHOBLASTS [J].
BOKKERINK, JPM ;
STET, EH ;
DEABREU, RA ;
DAMEN, FJM ;
HULSCHER, TW ;
BAKKER, MAH ;
VANBAAL, JA .
BIOCHEMICAL PHARMACOLOGY, 1993, 45 (07) :1455-1463
[6]  
GIVERHAUG T, 1996, IN PRESS ANAL METHYL
[7]   Clinical and experimental pharmacokinetic interaction between 6-mercaptopurine and methotrexate [J].
Innocenti, F ;
Danesi, R ;
DiPaolo, A ;
Lora, B ;
Favre, C ;
Nardi, M ;
Bocci, G ;
Nardini, D ;
Macchia, P ;
DelTacca, M .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1996, 37 (05) :409-414
[8]  
KLEMETSDAL B, 1995, EUR J CLIN PHARMACOL, V48, P495
[9]   ASSAY OF 6-THIOINOSINIC ACID AND 6-THIOGUANINE NUCLEOTIDES, ACTIVE METABOLITES OF 6-MERCAPTOPURINE, IN HUMAN RED BLOOD-CELLS [J].
LENNARD, L .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1987, 423 :169-178
[10]  
LENNARD L, 1990, LANCET, V336, P229